China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

XSEC:000999 Stock Report

Market Cap: CN¥57.9b

China Resources Sanjiu Medical & Pharmaceutical Future Growth

Future criteria checks 1/6

China Resources Sanjiu Medical & Pharmaceutical is forecast to grow earnings and revenue by 11.2% and 9.8% per annum respectively. EPS is expected to grow by 11.5% per annum. Return on equity is forecast to be 17.9% in 3 years.

Key information

11.2%

Earnings growth rate

11.5%

EPS growth rate

Pharmaceuticals earnings growth18.5%
Revenue growth rate9.8%
Future return on equity17.9%
Analyst coverage

Good

Last updated25 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

XSEC:000999 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202633,8924,3634,5075,74712
12/31/202531,1423,8653,4494,64214
12/31/202426,7463,3202,5993,3067
9/30/202425,8713,4103,5754,346N/A
6/30/202425,6993,3743,9954,783N/A
3/31/202425,6813,0663,8974,677N/A
12/31/202324,7392,8533,3354,192N/A
9/30/202324,5772,8993,0684,039N/A
6/30/202322,8252,8931,8542,876N/A
3/31/202320,1822,7591,8562,858N/A
1/1/202318,0792,4492,0553,006N/A
9/30/202216,3932,2511,5992,448N/A
6/30/202216,0812,1121,9192,734N/A
3/31/202215,7152,2531,2542,055N/A
1/1/202215,5442,0551,0121,885N/A
9/30/202115,5861,7731,2992,133N/A
6/30/202115,6231,9191,4892,213N/A
3/31/202114,5561,7171,1121,857N/A
12/31/202013,6371,5971,6022,224N/A
9/30/202013,9201,7101,3461,976N/A
6/30/202013,5051,4311,2031,828N/A
3/31/202014,4731,4551,7412,263N/A
12/31/201914,7942,0991,4111,949N/A
9/30/201914,1712,2891,4471,906N/A
6/30/201914,1222,3281,5172,012N/A
3/31/201913,5302,1761,3962,009N/A
12/31/201813,4281,4321,3111,911N/A
9/30/201813,0801,4551,3581,943N/A
6/30/201812,5941,387N/A1,906N/A
3/31/201812,0431,350N/A1,697N/A
12/31/201711,1201,302N/A1,599N/A
9/30/201710,3011,288N/A1,577N/A
6/30/20179,6991,303N/A1,459N/A
3/31/20179,3071,260N/A1,347N/A
12/31/20168,9821,198N/A1,392N/A
9/30/20168,5531,290N/A1,335N/A
6/30/20168,4851,258N/A1,320N/A
3/31/20168,1491,223N/A1,341N/A
12/31/20157,9001,249N/A1,260N/A
9/30/20157,7091,160N/A1,338N/A
6/30/20157,4751,107N/A1,330N/A
3/31/20157,4121,086N/A1,213N/A
12/31/20147,2771,036N/A1,184N/A
9/30/20146,770938N/A1,105N/A
6/30/20146,9591,064N/A1,152N/A
3/31/20147,1961,058N/A1,177N/A
12/31/20137,2931,109N/A1,345N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 000999's forecast earnings growth (11.2% per year) is above the savings rate (2.8%).

Earnings vs Market: 000999's earnings (11.2% per year) are forecast to grow slower than the CN market (26.2% per year).

High Growth Earnings: 000999's earnings are forecast to grow, but not significantly.

Revenue vs Market: 000999's revenue (9.8% per year) is forecast to grow slower than the CN market (13.8% per year).

High Growth Revenue: 000999's revenue (9.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 000999's Return on Equity is forecast to be low in 3 years time (17.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y